Atlas Trials

Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic Cancer

Clinical trial NCT07575191 · RECRUITING

Trial details

NCT number
NCT07575191
Sponsor
Smartwise Sweden AB
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer Non-resectable
Start date
2026-04-29
Primary completion
2027-12-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.